In brief: Velaglucerase (Vpriv) for Gaucher's disease.
D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D017277:Drug Approval; D005776:Gaucher Disease / Q000188:drug therapy* / Q000201:enzymology; D005962:Glucosylceramidase / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D005962:Glucosylceramidase